FMR LLC 13D and 13G filings for Sagimet Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-03-11 08:19 am Sale | 2024-03-08 | 13G | Sagimet Biosciences Inc. SGMT | FMR LLC | 742,392 2.444% | -1,179,664![]() (-61.38%) | Filing |
2024-02-09 09:49 am Sale | 2024-02-08 | 13G | Sagimet Biosciences Inc. SGMT | FMR LLC | 1,922,056 8.991% | -708,104![]() (-26.92%) | Filing |
2023-09-11 08:23 am Purchase | 2023-09-08 | 13G | Sagimet Biosciences Inc. SGMT | FMR LLC | 2,630,160 12.316% | 2,630,160![]() (New Position) | Filing |